In the modern clinical trial landscape, traditional recruitment methods are no longer sufficient to meet the rigorous demands of Phase II and III studies. As a leading China Patient Recruitment Factory, we recognize that the industry is shifting toward a semantic-driven approach. By leveraging Big Data, AI, and IoT, the "Data-Driven" model significantly reduces screen failure rates and accelerates the Time-to-Market for life-saving pharmaceuticals.
Utilizing historical trial data and demographic mapping to predict enrollment bottlenecks before they occur. Our systems analyze thousands of data points to identify "hotspots" for specific therapeutic areas.
Natural Language Processing (NLP) allows for the rapid analysis of electronic health records (EHR) to match eligible participants with complex protocol inclusion/exclusion criteria with 98% accuracy.
Integrating social media, healthcare apps, and community-based digital platforms to reach diverse and underrepresented patient populations globally.
Dongguan Trial Medical Co., Ltd. is a specialized manufacturer of remote clinical trial monitoring devices, decentralized clinical trial solutions, and digital research technologies. Established in 2016, the company is located in Dongguan, China, a major center for advanced manufacturing, medical technology development, and electronic innovation.
Operating from a modern facility covering more than 11,000 square meters, with a team of over 230 employees, Trial Medical is dedicated to developing and manufacturing innovative technologies that support clinical research organizations (CROs), pharmaceutical companies, and academic centers worldwide.
The transition toward Decentralized Clinical Trials (DCT) and Real-World Evidence (RWE) collection requires a robust hardware-software ecosystem. Our technical roadmap focuses on three core pillars:
Development of medical-grade sensors for continuous monitoring of vital signs (ECG, SpO2, Blood Pressure) that sync directly to cloud-based eCOA/ePRO platforms.
Ensuring that every patient interaction and data point is immutable and traceable, meeting the highest standards of FDA 21 CFR Part 11 and GDPR.
Established a "Direct-to-Patient" supply chain model that allows for the worldwide distribution of diagnostic kits and monitoring equipment directly from our Dongguan facility.
Navigating the global regulatory landscape is a core competency. Our products and recruitment strategies are fully compliant with:
Trial Medical
